We are serving since 1907

info@alembicusa.com908-393-9604

Corporate Profile

Our Company

Bridgewater, NJ – Alembic Pharmaceuticals, Inc., is a subsidiary of Alembic Pharmaceuticals Ltd., the oldest pharmaceutical company in India. Alembic Pharmaceuticals Limited., employs more than 8000 people and is one of the most respected, established and integrated pharmaceutical companies in Asia, supplying products to more than 90 countries around the world. Alembic Pharmaceuticals Ltd., is listed on the Bombay Stock Exchange under the stock symbol APLLTD.

Alembic is a vertically integrated organization, with expertise spanning the entire pharmaceuticals value chain: Research & Development (R&D), Manufacturing and Marketing of finished dosage formulations, as well as active pharmaceutical ingredients and intermediates.

76

No of Approved ANDAs

139

No of Filled
ANDAs

95

Cumulative DMF Filings

US Focus and Growth

Alembic has identified the United States as the key market for expansion and development. Alembic has experienced tremendous growth since its first launch in October 2015. The company now sells more than 35 products in the United States, representing more than 150+ SKUs under its own label. Alembic intends to launch 8 to 10 products each year over the next 3 years. In addition, Alembic now have fully operational oncology injectable facility. In total, Alembic has 225 ongoing projects, which include targets in dermatology, injectable, and ophthalmic.
“It’s very exciting to be part of such a dynamic organization that is focused on growth and serving our customers and, ultimately, patients,” said Armando Kellum, Vice President of Sales and Marketing at Alembic Pharmaceuticals, Inc.

For More information,
Contact: Armando Kellum Vice President,
Sales and Marketing (908) 393-9604
armando.kellum@alembicusa.com